UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new stake in Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 4,545,663 shares of the financial services provider’s stock, valued at approximately $843,311,000.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Headlands Technologies LLC bought a new position in Marsh & McLennan Companies in the 2nd quarter valued at approximately $29,000. Solstein Capital LLC purchased a new stake in Marsh & McLennan Companies during the 4th quarter valued at $25,000. KERR FINANCIAL PLANNING Corp purchased a new stake in Marsh & McLennan Companies during the 4th quarter valued at $27,000. Financial Life Planners purchased a new stake in Marsh & McLennan Companies during the 3rd quarter valued at $32,000. Finally, City Holding Co. purchased a new stake in Marsh & McLennan Companies during the 4th quarter valued at $29,000. 87.99% of the stock is owned by institutional investors.
Marsh & McLennan Companies Price Performance
NYSE:MRSH opened at $168.67 on Friday. Marsh & McLennan Companies, Inc. has a 52 week low of $156.60 and a 52 week high of $220.32. The stock has a market cap of $81.49 billion, a price-to-earnings ratio of 21.08, a price-to-earnings-growth ratio of 2.45 and a beta of 0.62. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 1.28.
Insider Activity
In related news, CEO John Q. Doyle sold 16,656 shares of the stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the completion of the sale, the chief executive officer owned 116,811 shares in the company, valued at approximately $18,889,506.81. This trade represents a 12.48% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.38% of the company’s stock.
Analyst Upgrades and Downgrades
A number of brokerages have weighed in on MRSH. Wells Fargo & Company decreased their target price on shares of Marsh & McLennan Companies from $203.00 to $178.00 and set an “equal weight” rating for the company in a research note on Thursday, April 9th. Citigroup upgraded shares of Marsh & McLennan Companies from a “neutral” rating to a “buy” rating and set a $200.00 target price for the company in a research note on Wednesday, May 6th. Raymond James Financial upgraded Marsh & McLennan Companies from an “outperform” rating to a “strong-buy” rating and set a $225.00 price objective for the company in a research note on Tuesday, February 17th. Bank of America reduced their price objective on Marsh & McLennan Companies from $181.00 to $174.00 and set an “underperform” rating for the company in a research note on Tuesday, April 14th. Finally, Piper Sandler reduced their price objective on Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating for the company in a research note on Tuesday, May 26th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, ten have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Marsh & McLennan Companies presently has an average rating of “Hold” and an average price target of $200.19.
View Our Latest Report on Marsh & McLennan Companies
Marsh & McLennan Companies Profile
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Read More
- Five stocks we like better than Marsh & McLennan Companies
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
